サイト内検索


登録済み会員ログイン




未登録の方はこちらから登録できます。
新規会員登録


ご利用案内

ご利用案内


連絡先

TEL.03-5812-5270
FAX.03-3831-0495
E-mail:info@spi-information.com


関連サイト・サービス

市場調査のご依頼、専門分野のイベント・フォーラムの開催などは シード・プランニングにて承っております。

シードプランニング

世界の医療・医薬品産業レポートのデータベースサービスは、sekairyo.comにてご利用いただけます。

sekairyo.com

医療従事者へのあらゆる形態の調査は、メドサークルにお任せ下さい。

メドサークル


セキュリティについて

当サイトのコンテンツ利用時に送信される機密情報は、Verisign認証の元暗号化されて送信されます。


Immunoprecipitation Market Research Report - Global Forecast till 2023

免疫沈降市場調査レポート‐2023年までの世界予測

レポート概要

免疫沈降市場調査レポート:種類別(個別免疫沈降、共免疫沈降、クロマチン免疫沈降、RNA免疫沈降)、製品別(キット、試薬、その他)、エンドユーザー別(CRO、その他)‐2023年までの予測

市場シナリオ

世界の免疫沈降市場は2018年から2023年までの予測期間中、約5.2% のCAGR、市場価値は5億6,200万ドルと予想されます。ライフサイエンスセクターにおける研究活動の増加や、自己免疫疾患に関連した抗原を同定する必要性が高まっていることがこの市場の成長を促しています。British Society of Immunologyによると2016年3月の時点で80を超える自己免疫疾患が同定されました。さらに官民投資の拡大、世界的なバイテク研究の活発化、個別化医療に関する認知度の向上が市場の成長を加速させています。一方で、予測期間中はタンパク質精製の代替技術の存在が市場の成長を妨げるでしょう。

主要プレイヤー各社は買収やパートナーシップ、事業拡大に取り組んでいます。例えばThermo Fisher Scientificは2018年に最適なバイオプロセスソリューションをデザインするため生物製剤デベロッパーとの連携を図るため、上海に新たなバイオプロセスデザインセンターを開設しました。

レポート詳細

目次

Table of Contents:

Chapter 1. Report Prologue

Chapter 2. Market Introduction
2.1 Definition
2.2 Scope of the Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations

Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation

Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities

Chapter 5. Market Factor Analysis
5.1 Porter’s Five Forces Analysis
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
5.2 Value Chain Analysis

Chapter 6. Global Immunoprecipitation Market, by Type
6.1 Introduction
6.2 Individual Immunoprecipitation
Market Estimates & Forecast, by Region, 2018-2023
Market Estimates & Forecast, by Country, 2018-2023
6.3 Co-Immunoprecipitation
Market Estimates & Forecast, by Region, 2018-2023
Market Estimates & Forecast, by Country, 2018-2023
6.4 Chromatin Immunoprecipitation
Market Estimates & Forecast, by Region, 2018-2023
Market Estimates & Forecast, by Country, 2018-2023
6.5 RNA Immunoprecipitation
Market Estimates & Forecast, by Region, 2018-2023
Market Estimates & Forecast, by Country, 2018-2023

Chapter 7. Global Immunoprecipitation Market, by Product
7.1 Introduction
7.2 Kit
Market Estimates & Forecast, by Region, 2018-2023
Market Estimates & Forecast, by Country, 2018-2023
7.3 Reagent
7.3.1 Antibodies
7.3.1.1 Primary
Market Estimates & Forecast, by Region, 2018-2023
Market Estimates & Forecast, by Country, 2018-2023
7.3.1.2 Secondary
Market Estimates & Forecast, by Region, 2018-2023
Market Estimates & Forecast, by Country, 2018-2023
7.3.2 Beads
7.3.2.1 Agarose Beads
Market Estimates & Forecast, by Region, 2018-2023
Market Estimates & Forecast, by Country, 2018-2023
7.3.2.2 Magnetic Beads
Market Estimates & Forecast, by Region, 2018-2023
Market Estimates & Forecast, by Country, 2018-2023
7.3.2.3 Buffers
Market Estimates & Forecast, by Region, 2018-2023
Market Estimates & Forecast, by Country, 2018-2023
7.4 Others
Market Estimates & Forecast, by Region, 2018-2023
Market Estimates & Forecast, by Country, 2018-2023

Chapter 8. Global Immunoprecipitation Market, by End User
8.1 Introduction
8.2 Pharmaceutical & Biotechnology Companies
Market Estimates & Forecast, by Region, 2018-2023
Market Estimates & Forecast, by Country, 2018-2023
8.3 Academic & Research Institutes
Market Estimates & Forecast, by Region, 2018-2023
Market Estimates & Forecast, by Country, 2018-2023
8.4 Contract Research Organizations
Market Estimates & Forecast, by Region, 2018-2023
Market Estimates & Forecast, by Country, 2018-2023
8.5 Others
Market Estimates & Forecast, by Region, 2018-2023
Market Estimates & Forecast, by Country, 2018-2023

Chapter 9. Global Immunoprecipitation Market, by Region
9.1 Introduction
9.2 Americas
9.2.1 North America
9.2.1.1 US
9.2.1.2 Canada
9.2.2 South America
9.3 Europe
9.3.1 Western Europe
9.3.1.1 Germany
9.3.1.2 France
9.3.1.3 Italy
9.3.1.4 Spain
9.3.1.5 UK
9.3.1.6 Rest of Western Europe
9.3.2 Eastern Europe
9.4 Asia-Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.4.6 Rest of Asia-Pacific
9.5 Middle East & Africa
9.5.1 Middle East
9.5.2 Africa

Chapter 10. Company Landscape
10.1 Introduction
10.2 Market Share Analysis
10.3 Key Development & Strategies

Chapter 11. Company Profiles
11.1 Abcam plc
11.1.1 Company Overview
11.1.2 Type Overview
11.1.3 Financials Overview
11.1.4 Key Developments
11.1.5 SWOT Analysis
11.2 GenScript
11.2.1 Company Overview
11.2.2 Type Overview
11.2.3 Financial Overview
11.2.4 Key Developments
11.2.5 SWOT Analysis
11.3 THERMO FISHER SCIENTIFIC
11.3.1 Company Overview
11.3.2 Type Overview
11.3.3 Financial Overview
11.3.4 Key Development
11.3.5 SWOT Analysis
11.4 Bio-Rad Laboratories, Inc.
11.4.1 Company Overview
11.4.2 Type Overview
11.4.3 Financial Overview
11.4.4 Key Development
11.4.5 SWOT Analysis
11.5 Merck KGaA
11.5.1 Company Overview
11.5.2 Type Overview
11.5.3 Financial overview
11.5.4 Key Developments
11.5.5 SWOT Analysis
11.6 BioLegend, Inc.
11.6.1 Company Overview
11.6.2 Type Overview
11.6.3 Financial Overview
11.6.4 Key Developments
11.6.5 SWOT Analysis
11.7 Takara Bio Inc.
11.7.1 Overview
11.7.2 Type Overview
11.7.3 Financial Overview
11.7.4 Key Developments
11.7.5 SWOT Analysis
11.8 Rockland Immunochemicals Inc.
11.8.1 Overview
11.8.2 Type Overview
11.8.3 Financials
11.8.4 Key Developments
11.8.5 SWOT Analysis
11.9 Cell Signaling Technology, Inc.
11.9.1 Overview
11.9.2 Type Overview
11.9.3 Financials
11.9.4 Key Developments
11.9.5 SWOT Analysis
11.10 Geno Technology Inc.
11.10.1 Overview
11.10.2 Type Overview
11.10.3 Financials
11.10.4 Key Developments
11.10.5 SWOT Analysis

Chapter 12 MRFR Conclusion
12.1 Key Findings
12.1.1 From CEO’s Viewpoint
12.1.2 Unmet Needs of the Market
12.2 Key Companies to Watch
12.3 Predictions for the Immunoprecipitation Industry

Chapter 13. Appendix

LIST OF TABLES
Table 1 Global Immunoprecipitation Market Synopsis, 2018-2023
Table 2 Global Immunoprecipitation Market Estimates and Forecast, 2018-2023 (USD Million)
Table 3 Global Immunoprecipitation Market, by Region, 2018-2023 (USD Million)
Table 4 Global Immunoprecipitation Market, by Type, 2018-2023 (USD Million)
Table 5Global Immunoprecipitation Market, by Product, 2018-2023 (USD Million)
Table 6 Global Immunoprecipitation Market, by End User, 2018-2023 (USD Million)
Table 7 North America: Immunoprecipitation Market, by Type, 2018-2023 (USD Million)
Table 8 North America: Immunoprecipitation Market, by Product, 2018-2023 (USD Million)
Table 9 North America: Immunoprecipitation Market, by End User, 2018-2023 (USD Million)
Table 10 US: Immunoprecipitation Market, by Type, 2018-2023 (USD Million)
Table 11 US: Immunoprecipitation Market, by Product, 2018-2023 (USD Million)
Table 12 US: Immunoprecipitation Market, by End User, 2018-2023 (USD Million)
Table 13 Canada: Immunoprecipitation Market, by Type, 2018-2023 (USD Million)
Table 14 Canada: Immunoprecipitation Market, by Product, 2018-2023 (USD Million)
Table 15 Canada: Immunoprecipitation Market, by End User, 2018-2023 (USD Million)
Table 16 South America: Immunoprecipitation Market, by Type, 2018-2023 (USD Million)
Table 17 South America: Immunoprecipitation Market, by Product, 2018-2023 (USD Million)
Table 18 South America: Immunoprecipitation Market, by End User, 2018-2023 (USD Million)
Table 19 Europe: Immunoprecipitation Market, by Type, 2018-2023 (USD Million)
Table 20 Europe: Immunoprecipitation Market, by Product, 2018-2023 (USD Million)
Table 21Europe: Immunoprecipitation Market, by End User, 2018-2023 (USD Million)
Table 22Western Europe: Immunoprecipitation Market, by Type, 2018-2023 (USD Million)
Table 23Western Europe: Immunoprecipitation Market, by Product, 2018-2023 (USD Million)
Table 24Western Europe: Immunoprecipitation Market, by End User, 2018-2023 (USD Million)
Table 25Eastern Europe: Immunoprecipitation Market, by Type, 2018-2023 (USD Million)
Table 26Eastern Europe: Immunoprecipitation Market, by Product, 2018-2023 (USD Million)
Table 27Eastern Europe: Immunoprecipitation Market, by End User, 2018-2023 (USD Million)
Table 28Asia-Pacific: Immunoprecipitation Market, by Type, 2018-2023 (USD Million) Table 29Asia-Pacific: Immunoprecipitation Market, by Product, 2018-2023 (USD Million)
Table 30 Asia-Pacific: Immunoprecipitation Market, by End User, 2018-2023 (USD Million)
Table 31Middle East & Africa: Immunoprecipitation Market, by Type, 2018-2023 (USD Million)
Table 32Middle East & Africa: Immunoprecipitation Market, by Product, 2018-2023 (USD Million)
Table 33Middle East & Africa: Immunoprecipitation Market, by End User, 2018-2023 (USD Million)

LIST OF FIGURES
Figure 1 Research Process
Figure 2 Market Structure for Global Immunoprecipitation Market
Figure 3 Market Dynamics for Global Immunoprecipitation Market
Figure 4 Global Immunoprecipitation Market Share, by Type, 2017
Figure 5 Global Immunoprecipitation Market Share, by Product, 2017
Figure 6 Global Immunoprecipitation Market Share, by End User, 2017
Figure 7 Global Immunoprecipitation Market Share, by Region, 2017
Figure 8 North America: Immunoprecipitation Market Share, by Country, 2017
Figure 9 Europe: Immunoprecipitation Market Share, by Country, 2017
Figure 10 Asia-Pacific: Immunoprecipitation Market Share, by Country, 2017
Figure 11 Middle East & Africa: Immunoprecipitation Market Share, by Country, 2017
Figure 12 Global Immunoprecipitation Market: Company Share Analysis, 2017 (%)
Figure 13 Abcam plc: Key Financials
Figure 14 Abcam plc: Segmental Revenue
Figure 15 Abcam plc: Geographical Revenue
Figure 16 GenScript: Key Financials
Figure 17 GenScript: Segmental Revenue
Figure 18 GenScript: Geographical Revenue
Figure 19 Thermo Fisher Scientific: Key Financials
Figure 20 Thermo Fisher Scientific: Segmental Revenue
Figure 21 Thermo Fisher Scientific: Geographical Revenue
Figure 22 Bio-Rad Laboratories, Inc.: Key Financials
Figure 23 Bio-Rad Laboratories, Inc.: Segmental Revenue
Figure 24 Bio-Rad Laboratories, Inc.: Geographical Revenue
Figure 25 Merck KGaA: Key Financials
Figure 26 Merck KGaA: Segmental Revenue
Figure 27 Merck KGaA: Geographical Revenue
Figure 28 BioLegend, Inc.: Key Financials
Figure 29 BioLegend, Inc.: Segmental Revenue
Figure 30 BioLegend, Inc.: Geographical Revenue
Figure 31 Takara Bio Inc.: Key Financials
Figure 32 Takara Bio Inc.: Segmental Revenue
Figure 33 Takara Bio Inc.: Geographical Revenue
Figure 34 Rockland Immunochemicals Inc.: Key Financials
Figure 35 Rockland Immunochemicals Inc.: Segmental Revenue
Figure 36 Rockland Immunochemicals Inc.: Geographical Revenue
Figure 37 Cell Signaling Technology, Inc.: Key Financials
Figure 38 Cell Signaling Technology, Inc.: Segmental Revenue
Figure 39 Cell Signaling Technology, Inc.: Geographical Revenue
Figure 40 Geno Technology Inc.: Key Financials
Figure 41 Geno Technology Inc.: Segmental Revenue
Figure 42 Geno Technology Inc.: Geographical Revenue

発刊日

2019/05

体裁

PDF / 90ページ

販売価格

4,450USD

発行

Market Research Future

備考

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※販売価格はシングルユーザーライセンスのものとなります。他のライセンス形態・価格に関しましてはご相談下さい。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

関連カテゴリ

バイオ・ゲノム・再生医療 / 診断・検査薬

購入・お問い合わせ

このレポートを購入

詳細を問い合わせる


PAGE